Structural Characterization and Anti-Inflammatory Effect in Hepatocytes of a Galactoglucan from Antrodia Camphorata Mycelium

Huiling Tang,Wenbing Nie,Jinna Xiao,Zhengqi Zha,Qiuli Chen,Hongping Yin
DOI: https://doi.org/10.1039/c8ra10347j
IF: 4.036
2019-01-01
RSC Advances
Abstract:The galactoglucan ACP2 was isolated from cultured Antrodia camphorata mycelium through anion-exchange column chromatography and Sephadex G-100 chromatography and shown to exhibit hepatoprotective function in L02 cells. Based on monosaccharide composition analysis, ACP2 was mainly composed of glucose, galactose, and 6-deoxyglucose in a molar ratio of 5:2:1. The average molecular weight of ACP2 was 1.93 x 10(4) Da. The primary structure of ACP2 was elucidated with Fourier-transform infrared spectroscopy, gas chromatography-mass spectrometry, and nuclear magnetic resonance spectroscopy. The results indicated the following composition: 6)-linked--d-Galp-(1, 6)-linked--d-Glcp-(1, 3)-linked--d-Glcp-(1, and 2,4)-linked--d-Glcp-(1, with terminal 6-deoxy--d-Glcp and -d-Glcp. ACP2 alleviated lipopolysaccharide-induced hepatocyte inflammation by down-regulating the expressions of COX-2, IL-1, TNF- and IL-6. The decreased expressions of TLR4, MyD88, NF-B, and phosphorylated p38 in ACP2-treated L02 cells indicated that ACP2 might ameliorate inflammation through the TLR4 and p38/NF-B signaling pathways.
What problem does this paper attempt to address?